Evidence map›Paper›PMID 17932053›Full record

ArticleNucleic acids research2007

FLAG assay as a novel method for real-time signal generation during PCR: application to detection and genotyping of KRAS codon 12 mutations.

Giulia Amicarelli, Erlet Shehi, G Mike Makrigiorgos, Daniel Adlerstein

Open access · goldAbstract readValidation Study
In one paragraph

Article in Nucleic acids research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. RAS testing in metastatic colorectal cancer: advances in Europe.Virchows Archiv : an international journal of pathology · 2016
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Giulia AmicarelliDiaSorin SpA, via Crescentino snc, 13040 Saluggia (VC), Italy.
Erlet Shehi
G Mike Makrigiorgos
Daniel Adlerstein
Harvard University · USSprint (United States) · US

Funding

GENOME AMPLIFICATION TOLERANT TO SAMPLE DEGRADATIONR33CA111994 · NCI · DANA-FARBER CANCER INST · PI MAKRIGIORGOS, G. MIKE · 2007 to 2008
$656k
CIRCULATING DNA AMPLIFICATION & COLON CA DETECTIONR21CA115439 · NCI · DANA-FARBER CANCER INST · PI MAKRIGIORGOS, G. M · 2006 to 2007
$353k
GENOME AMPLIFICATION TOLERANT TO SAMPLE DEGRADATIONR21CA111994 · NCI · DANA-FARBER CANCER INSTITUTE · PI MAKRIGIORGOS, G. MIKE · 2005 to 2006
$290k
NCI NIH HHS CA111994-01NCI NIH HHS CA115439-01NCI NIH HHS R21 CA111994NCI NIH HHS R21 CA115439NCI NIH HHS R33 CA111994
6 · The paper itself

Abstract

Real-time signal generation methods for detection and characterization of low-abundance mutations in genomic DNA are powerful tools for cancer diagnosis and prognosis. Mutations in codon 12 of the oncogene KRAS, for example, are frequently found in several types of human cancers. We have developed a novel real-time PCR technology, FLAG (FLuorescent Amplicon Generation) and adapted it for simultaneously (i) amplifying mutated codon 12 KRAS sequences, (ii) monitoring in real-time the amplification and (iii) genotyping the exact nucleotide alteration. FLAG utilizes the exceptionally thermostable endonuclease PspGI for real-time signal generation by cleavage of quenched fluorophores from the 5'-end of the PCR products and, concurrently, for selecting KRAS mutations over wild type. By including peptide-nucleic-acid probes in the reaction, simultaneous genotyping is achieved that circumvents the requirement for sequencing. FLAG enables high-throughput, closed-tube KRAS mutation detection down to approximately 0.1% mutant-to-wild type. The assay was validated on model systems and compared with allele-specific PCR sequencing for screening 27 cancer specimens. Diverse applications of FLAG for real-time PCR or genotyping applications in cancer, virology or infectious diseases are envisioned.

Indexed as

Genes, rasCell LineCodonColorectal NeoplasmsDNA Mutational AnalysisGenotypeHumansOligonucleotide ProbesPeptide Nucleic AcidsPolymerase Chain ReactionProto-Oncogene ProteinsProto-Oncogene Proteins p21(ras)ras ProteinsTime FactorsCodonKRAS protein, humanOligonucleotide ProbesPeptide Nucleic AcidsProto-Oncogene ProteinsProto-Oncogene Proteins p21(ras)ras Proteins

Identifiers

PMID17932053
PMCPMC2095824
OpenAlexW2119167595

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.